Zentalis Pharmaceuticals ...
(ZNTL)
undefined
undefined%
At close: undefined
3.06
-2.24%
After-hours Jan 06, 2025, 07:24 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -3.39 | -4.82 | -21.85 | -17.98 | -17.95 | -19.89 |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | 29.92K |
| PB Ratio | 2.27 | 2.45 | 9.85 | 6.39 | 10.84 | 16.91 |
| P/FCF Ratio | -4.75 | -6.4 | -22.4 | -24.34 | -21.08 | -17.12 |
| P/OCF Ratio | -4.77 | -6.5 | -23.29 | -24.55 | -21.27 | -17.28 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -1.73K |
| Debt / Equity Ratio | n/a | 0.10 | 0.12 | n/a | n/a | n/a |
| Quick Ratio | 7.16 | 8.10 | 8.08 | 12.07 | 5.64 | 4.30 |
| Current Ratio | 7.16 | 7.98 | 7.98 | 12.07 | 5.64 | 4.30 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.00 |
| Interest Coverage | n/a | -88.27 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.67 | -0.51 | -0.45 | -0.36 | -0.6 | -0.85 |
| Return on Assets (ROA) | -0.53 | -0.41 | -0.36 | -0.32 | -0.45 | -0.51 |
| Return on Capital (ROIC) | -0.52 | -0.47 | -0.53 | -0.35 | -0.53 | -0.68 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 100.00% |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -150.48K% |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -167.34K% |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -169.88K% |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | -174.84K% |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -169.51K% |